Quarterly report pursuant to Section 13 or 15(d)

Common Stock Equivalents (Details)

v3.19.1
Common Stock Equivalents (Details) - shares
9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents 7,846,765 2,018,668
Convertible Notes [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents 4,960,800
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents 2,177,314 1,263,859
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents 708,651 754,809